Ametris_ADDS_Atlanta_2026_Logo_Final_Reverse

Ametris Digital Data Summit Atlanta 2026

February 23-25   |   ATLANTA, GA

WATCH VIDEO
ADDS 2024

ActiGraph Digital Data Summit 2025

February 10-12     |     Pensacola Beach, FL

Driving Adoption of Digital Measures in Clinical Research and Development

The Ametris Digital Data Summit is a one-of-a-kind scientific event focusing on the practical application of wearable digital health technology (DHT) in clinical research. Since 2022, ADDS has brought together multidisciplinary leaders across the digital health ecosystem to explore the latest research, case studies, and innovations driving the adoption of sensor-based measures in clinical research and drug development. 

ADDS 2026 will feature expert-led presentations and collaborative discussions to address topics including physical activity and mobility, sleep and scratch, AI, regulatory insights, methodology, and pharma innovation. We invite scientists, public health researchers, clinicians, regulators, and technology experts to join us Feb 23-25 in Atlanta, GA for this important event. Together, we can address opportunities and challenges facing broader adoption of digital measures in clinical research.

AG_Marketing_ADDS_2022_Icons_KeynoteSpeakers_White

Featured Speakers

Check back regularly for new speakers!

Why Attend ADDS Atlanta 2026?

ADDS is your chance to learn from, network with, and develop collaborations with colleagues from a variety of disciplines, including clinicians, data scientists, clinical trialists, digital health technology specialists, and public health researchers.

Scientific Case Studies

Client Case Studies

Panel Discussions

Panel Discussions

Networking Forums

Networking Forums

Scientific Poster Sessions

Scientific Poster Session

Partner Exhibits

Partner Exhibits

ADDS Atlanta 2026 Activity

We're excited to add a new activity to the ADDS agenda this year, providing opportunities for deeper discussions, actionable takeaways, and expanded networking within the digital health community.

Pre-Conference Workshop
Huntington's Disease

Monday, February 23rd, 1 - 5 PM ET

This workshop will examine the limitations of current HD endpoints in clinical trial design, assess the evolving landscape and remaining gaps in digital measurement development, and incorporate regulatory perspectives on the use of passive digital health technologies.

Through multi-stakeholder discussion, participants will align on evidence-generation priorities, resulting in a structured gap mapping of key challenges and existing validation evidence, a shared framework to guide future evidence generation, and a call-to-action paper and/or the formation of a focused working group to drive next steps.

This session is designed for those committed to improving the rigor, relevance, and efficiency of HD clinical trials.

Seats are limited! Please check the box on the ticket form to reserve your seat.

AG_Marketing_ADDS_2022_Icons_StudentPosterContest_WhiteScientific Poster Session

During ADDS Atlanta 2026, Ametris will host a scientific poster session where selected researchers will have the opportunity to present their work with digital health technology (DHT) to this diverse audience of digital health leaders and innovators.

VIEW PRESENTERS

What Did Attendees Say About ADDS?

It's nice to have a conference that has a very specific focus, because we can dive much deeper into that and really get into the meat of the data. You can get into a much deeper understanding of the particular topic as well as some of the advancements in the field.

Ariel Dowling, PhD

Head of Sensing and Measurement | Takeda

It's a perfect thing when you can come to a conference, and you can meet people and immediately realize that you have things in common and can help each other; to meet other people who are really in different fields, but experiencing some of the same issues and develop potential collaborations across the board.

Jonathan Soslow

Pediatric Cardiologist | Vanderbuilt University

An event like this brings talent that you normally are not exposed to, and as you see these presentations, you're shocked as to how much innovation is out there.

Peter Fernandes

CEO | Bellerophon Therapeutics

I think a lot of us do research in the technology and how we can apply it to our specific research interests or populations, but learning how to cross those boundaries between clinical populations is important.

Jennifer Schrack, PhD

Professor of Epidemiology and Director | Center on Aging and Health at the Johns Hopkins University

Ariel Dowling
Dr. Jonathan Soslow
Peter Fernandes
Jennifer Shrack, PhD

Ametris Welcomes our Event Sponsors

AliveCor
ISMBP